Evidence map›Paper›PMID 40576621›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2025

Disruptions in primary visual cortex physiology and function in a mouse model of Timothy syndrome.

Rosie Craddock, Cezar M Tigaret, Frank Sengpiel

Abstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rosie CraddockSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, United Kingdom.
Cezar M TigaretNeuroscience and Mental Health Innovation Institute, Maindy Road, Cardiff CF24 4HQ, United Kingdom.
Frank SengpielSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, United Kingdom.ORCID 0000-0002-7060-1851

Funding

Biotechnology and Biological Sciences Research CouncilMRC New Investigator Research Grant MR/V034111/1SWBio Doctoral Training Program
6 · The paper itself

Abstract

Timothy syndrome (TS) is a rare genetic disorder caused by mutations in the CACNA1C gene, which encodes the L-type calcium channel α1 CaV1.2 subunit. While it is expressed throughout the body, the most serious symptoms are cardiac and neurological. Classical TS type 1 (TS1) and TS type 2 (TS2) mutations cause prolonged action potentials (APs) in cardiomyocytes and in induced neurons derived from pluripotent stem cells taken from TS patients, but the effects of TS mutations on neuronal function in vivo are not fully understood. TS is frequently associated with autistic traits, which in turn have been linked to altered sensory processing. Using the TS2-neo mouse model, we analyzed the effects of TS2 mutation on the visual system. We observed a widening of APs of pyramidal cells in ex vivo patch clamp recordings and an increase in the density of parvalbumin-positive cells in the primary visual cortex. Neurons from TS2-neo mice recorded extracellularly in vivo were less likely to respond to visual stimuli of low spatial frequency, but more likely to respond to visual stimuli of mid-to-high spatial frequency, compared to those from wild-type mice. These results point to a basic processing abnormality in the visual cortex of TS2-neo mice.

Indexed as

Autistic DisorderLong QT SyndromePrimary Visual CortexSyndactylyVisual CortexAction PotentialsAnimalsCalcium Channels, L-TypeDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, TransgenicMutationNeuronsParvalbuminsCACNA1C protein, mouseCalcium Channels, L-TypeParvalbuminsaction potentialcontrast sensitivitymouseTimothy syndromevisual cortex

Identifiers

PMID40576621
PMCPMC12203796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.